A Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver Health

NCT05808049 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease

Interventions

OTHER: MXP22 (Probiotic and antioxidant capsule)
OTHER: Placebo (Microcrystalline Cellulose)

Sponsor

Vedic Lifesciences Pvt. Ltd.